Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 14, 2011 02:20 ET | Source: Affitech A/S

Storaktionærmeddelelse - Krosalter Enterprises Ltd.

København og Oslo, 14. juli 2011, 2011-07-14 08:20 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), der udvikler antistoflægemidler, meddeler, at Krosalter Enterprises Ltd. Cypern d. 13....
July 14, 2011 02:20 ET | Source: Affitech A/S

Major shareholder announcement - Krosalter Enterprises Ltd.

Copenhagen and Oslo, 14th July, 2011, 2011-07-14 08:20 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today, that Krosalter Enterprises Ltd....
July 14, 2011 02:20 ET | Source: Affitech A/S

Storaktionærmeddelelse - Transnova Investments Ltd.

København og Oslo, 14. juli 2011, 2011-07-14 08:20 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), der udvikler antistoflægemidler, meddeler i henhold til værdipapirlovens §29 og...
July 14, 2011 02:20 ET | Source: Affitech A/S

Major shareholder announcement - Transnova Investments Ltd.

Copenhagen and Oslo, 14th July, 2011, 2011-07-14 08:20 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today according to the Danish...
June 16, 2011 08:54 ET | Source: Affitech A/S

Affitech A/S modtager licensbetaling på 18,6 millioner kr. for udvikling af nyt anti-VEGF antistoflægemiddel i Rusland

København og Oslo, 16. juni 2011, 2011-06-16 14:54 CEST (GLOBE NEWSWIRE) -- Første betaling i henhold til strategisk russisk aftale Førende antistoflægemiddel AT001/r84 godt på vej,...
June 16, 2011 08:54 ET | Source: Affitech A/S

Affitech A/S receives EUR 2.5 million license fee for development of new anti-VEGF antibody drug in Russia

Copenhagen and Oslo, 16th June, 2011, 2011-06-16 14:54 CEST (GLOBE NEWSWIRE) -- First payment under Russian strategic alliance Lead antibody drug AT001/r84 in good progress,...
June 11, 2011 04:27 ET | Source: Affitech A/S

Affitech A/S and NTS Plus amend Research & Development and Licensing agreement of April 2010

Copenhagen and Oslo, 11th June, 2011, 2011-06-11 10:27 CEST (GLOBE NEWSWIRE) -- Rights and obligations under the R&D and Licensing Agreement transferred from NTS Plus to new...
June 11, 2011 04:27 ET | Source: Affitech A/S

Affitech A/S og NauchTeckStroy Plus ændrer forsknings-, udviklings- og licensaftale indgået i april 2010

København og Oslo, 11. juni 2011, 2011-06-11 10:27 CEST (GLOBE NEWSWIRE) -- Rettigheder og forpligtelser i henhold til forsknings-, udviklings-, og licensaftalen...
June 07, 2011 07:34 ET | Source: Affitech A/S

Affitech A/S frifindes i retssag og tillægges 500.000 kr. i sagsomkostninger

København og Oslo, den 7. juni 2011, 2011-06-07 13:34 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (Nasdaq OMX: AFFI), der udvikler antistoflægemidler, oplyser, at Østre Landsret har afsagt dom til...
June 07, 2011 07:34 ET | Source: Affitech A/S

High Court decides in favor of Affitech and awards the Company costs in the amount of DKK 500.000

Affitech A/S, (Nasdaq OMX: AFFI) the antibody medicines company, today announced that the Danish High Court has found in its favor in the court case brought by some minority shareholders which...